Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Aldeyra Therapeutics

Tracked across 4 events · 176 articles · First seen Apr 03, 2025 · Last active Jun 09, 2026

Sentiment
-19
Attention
6
Events
4
Relationships
22
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -75
Business
Impact: Aldeyra Therapeutics is the primary defendant in multiple class action lawsuits filed by various law firms, alleging that the company made false and misleading statements regarding the clinical trials of its drug candidate, reproxalap. The company's stock price fell significantly after the United States — Food and Drug Administration issued a Complete Response Letter for reproxalap.
Apr 24, 2026 · 80 articles
3 0
Business
Apr 25, 2026 · 6 articles
4 0
Business
Apr 01, 2026 · 16 articles
4 0
Business
Apr 01, 2026 · 74 articles
DJS Law Group Aldeyra Therapeutics
DJS Law Group Aldeyra Therapeutics
James Wilson Aldeyra Therapeutics
James Wilson Aldeyra Therapeutics
Peretz Bronstein Aldeyra Therapeutics
Peretz Bronstein Aldeyra Therapeutics
Nathan Miller Aldeyra Therapeutics
Nathan Miller Aldeyra Therapeutics
Faruqi & Faruqi Aldeyra Therapeutics
Faruqi & Faruqi Aldeyra Therapeutics
Lawrence Rosen Aldeyra Therapeutics
Lawrence Rosen Aldeyra Therapeutics
Philip Kim Aldeyra Therapeutics
Philip Kim Aldeyra Therapeutics
Rosen Law Firm Aldeyra Therapeutics
Rosen Law Firm Aldeyra Therapeutics
ERGEN INTELLIGENCE
Track Aldeyra Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.